Abstract
Reporting research is as important a part of a study as its design or analysis. Reporting guidelines (RGs) provide structured advice on how to report research studies clearly and adequately. This study aimed to review the development of RGs of Chinese medicine (CM) and to provide recommendations for improvement. Through a systematic search of the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network and electronic databases up to January 1, 2022, we identified a total of 15 RGs of CM, and further summarized their characteristics and applications. In addition, we reviewed the development of international RGs and analyzed its impact for CM. Compared with the generic RGs, the reporting standards of CM have been rapidly developed over the last 10 years, of which 57% were issued in recent 3 years (2019–2021). Currently, the system of RGs of CM has been established, especially for clinical trials, including various CM interventions and covering the guidelines from trial registration, protocol, results publication to the evidence synthesis and clinical practice guideline. However, the application of RGs of CM is suboptimal. It is necessary to take further measures to promote practical application, improve journals’ endorsement, and establish quality monitoring procedures for RGs of CM in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
